Search

Search Results
Results 5391 - 5400 of 17262 for Active treatment
  • News - 22 Aug 2025
    CVD is the leading cause of death worldwide but does not affect people equally. In many countries, Black, South Asian and Indigenous peoples have higher rates of heart disease, diabetes, or high blood...
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Epipen intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Epipen Jr intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Adrenaline Viatris intended for persons living in Australia.
  • Drug - 22 Aug 2025
    Consumer Medicine Information (CMI) about Adrenaline Jr Viatris intended for persons living in Australia.
  • Drug - 21 Aug 2025
    Consumer Medicine Information (CMI) about Benlysta intended for persons living in Australia.
  • Drug - 21 Aug 2025
    Consumer Medicine Information (CMI) about Alimta intended for persons living in Australia.
  • News - 18 Aug 2025
    Cancer remains one of the most challenging diseases to treat, as conventional therapies like chemotherapy and radiotherapy are often hindered by poor specificity, systemic toxicity, and damage to...
  • News - 13 Aug 2025
    Thanks to new advances in cancer care, more and more people are surviving cancer, with a projected total of 22.5 million survivors by 2032.
  • News - 12 Aug 2025
    Cats with dementia have brain changes similar to those of people with Alzheimer's disease, offering a valuable model for studying the condition in humans, a study says.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.